| BXMYX | PASIX | BXMYX / PASIX | |
| Total Expense Ratio | 3.75 | 2.59 | 145% |
| Annual Report Gross Expense Ratio | 3.75 | 3.33 | 113% |
| Fund Existence | 11 years | 20 years | - |
| Gain YTD | 5.321 | 3.645 | 146% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.78B | 266M | 1,419% |
| Annual Yield % from dividends | 5.33 | 4.69 | 114% |
| Returns for 1 year | 10.86 | 1.30 | 833% |
| Returns for 3 years | 28.29 | 13.72 | 206% |
| Returns for 5 years | 23.06 | 5.56 | 414% |
| Returns for 10 years | 44.34 | 15.96 | 278% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NXTI | 35.16 | N/A | N/A |
| Simplify Next Intangible Core Index ETF | |||
| KMLI | 9.91 | N/A | N/A |
| KraneShares 2x Long MELI Daily ETF | |||
| IVOO | 127.35 | -0.70 | -0.55% |
| Vanguard S&P Mid-Cap 400 ETF | |||
| WIP | 38.83 | -0.24 | -0.61% |
| StateStreet®SPDR®FTSEIntGovInfProtdBdETF | |||
| BBP | 98.10 | -2.16 | -2.15% |
| Virtus LifeSci Biotech Products ETF | |||